A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices, according to a new study.
http://www.cancernetwork.com/gastrointestinal-cancer/novel-calculator-guides-treatment-choice-esophageal-cancer
Novel Calculator Guides Treatment Choice in Esophageal Cancer